Shire
Shire Pharmaceuticals Ireland is involved in the research, development and marketing of prescription medicines. Its particular focus is medicines for attention deficit hyperactivity disorder, human genetic therapies and gastrointestinal diseases. It employs 119 people in Dublin and is part of Swiss company Shire AG.
Shire was acquired by Takeda Pharmaceutical Company on 8 January 2019.
Financial Data
-
31st Dec 19 Source: CRO
- €1.7 billion turnover
-
€121.9 million
profit - 183 employees
-
31st Dec 18 Source: CRO
- €13.7 billion turnover
-
€2.4 billion
profit - 22,000 employees
- 11 more years available »
Ranking
By Turnover
(€1.7 billion)- 60th in Top Companies
- 11th in Pharma
By Employees
(183)- 633rd in Top Companies
- 58th in Pharma
-
- 183
- €1.7 billion
Employees
- Susan Hynes Vice President}
Latest News
- 2:15pm Brussels warned not to delay tighter capital rules for EU banks
- 1:01pm Labour Court set to propose 5.6% pay rise for construction workers – report
- Oct 23 Eir planning to sell almost half of Irish fibre network
- Oct 22 Methane leak near Cop26 venue underscores emissions challenge
- Oct 22 Goldman grants stock worth $30m in five years to chief David Solomon